Home › Brands › The Cannabist Company
How this page was made
Also known as: Columbia Care · Cannabist Company Holdings · CCHWF

The Cannabist Company

A U.S. multi-state cannabis operator, formerly known as Columbia Care, that owns retail stores and house product brands across several state markets.

Sourced and fact-checked
7 cited sources
Published 1 week ago
How this page was made
↯ The honest take

The Cannabist Company is the rebrand of Columbia Care, one of the older U.S. multi-state operators. It runs dispensaries and cultivation in a handful of legal states and owns house brands like Seed & Strain and Triple Seven. Like most U.S. MSOs, it has reported large losses, carries significant debt, and operates in a sector where the legal landscape keeps shifting. Treat any specific claim about store count, revenue, or licensing as something to verify against current filings rather than press releases.

What it is

The Cannabist Company is a U.S. multi-state cannabis operator headquartered in New York. It was founded in 2012 as Columbia Care and rebranded under the Cannabist name in 2023, taking the consumer-facing name it had been using for its retail dispensaries since 2021 [1][2]. The company is publicly traded in Canada on the Canadian Securities Exchange under the ticker CBST and on U.S. over-the-counter markets as CBSTF [3].

It operates as a vertically integrated business, meaning it grows cannabis, manufactures finished products (flower, vapes, edibles, concentrates), and sells them through its own dispensaries as well as wholesaling to third-party retailers in states that allow it [1][3].

Ownership and corporate structure

The legal parent entity is Cannabist Company Holdings Inc., a Canadian-domiciled holding company with U.S. operating subsidiaries — a structure common among U.S. cannabis operators that list in Canada because U.S. exchanges do not list plant-touching cannabis companies [3]. Columbia Care Inc. completed its name change to The Cannabist Company Holdings Inc. in 2023 [2].

A previously announced 2022 merger with Cresco Labs was terminated in 2023; the two companies did not combine [4]. As of this profile's check date, Cannabist remains an independent operator with no announced parent acquirer.

Market and category focus

Cannabist's footprint has historically spanned both medical and adult-use markets in states including Colorado, New Jersey, New York, Virginia, Pennsylvania, Ohio, Florida, Massachusetts, Maryland, Delaware, West Virginia, and the District of Columbia [1][3]. The exact list of active operations has changed over time as the company has divested assets — for example, announcing the sale of certain Florida and other state operations in 2024 to reduce debt [5]. Readers should consult the company's most recent SEDAR+ filings or investor disclosures for the current state-by-state footprint rather than relying on older marketing materials.

Notable house brands

Cannabist sells products under several in-house brands in addition to the Cannabist retail banner [1][3]:

Availability of any given brand varies by state because of how U.S. cannabis licensing works — products cannot legally cross state lines. This profile does not recommend specific products; consumers should check lab certificates of analysis and current menus locally.

Reputation, financials, and controversies

As a publicly traded operator, Cannabist's financial performance is disclosed in regular filings. Like most U.S. MSOs, the company has reported substantial net losses and carries meaningful debt loads, and its share price has declined sharply from highs during the 2021 cannabis stock cycle [5][6]. In 2024 the company disclosed restructuring efforts including asset sales and refinancing of debt maturities [5].

The 2022 announcement and 2023 termination of the Cresco Labs merger was a significant event for shareholders; the deal had been pitched as creating the largest U.S. MSO by revenue before regulatory and market conditions led the companies to walk away [4].

We are not aware of widely reported product-safety recalls specific to Cannabist house brands at the time of this profile, but recall histories vary by state and are tracked by individual state cannabis regulators rather than nationally. Verify with the relevant state agency before assuming a clean record in any given market.

Cannabist products are sold only in U.S. state-legal cannabis markets where the company holds licenses. Cannabis remains a Schedule I substance under U.S. federal law as of this profile's check date, and no Cannabist product is legally shipped across state lines [7]. Hemp-derived CBD or other federally legal products, if any, would be governed separately under the 2018 Farm Bill framework; this profile does not verify any specific Cannabist hemp SKUs.

What to verify before relying on brand claims

Before treating any specific claim about The Cannabist Company as current, check:

  1. Current state footprint and store count — via the company's latest annual or quarterly filing on SEDAR+ [3].
  2. License status — directly with the cannabis regulator in the state in question. Licenses can be suspended, transferred, or sold.
  3. Product availability — local dispensary menus; brand presence in one state does not imply presence in another.
  4. Lab results / COAs — for any specific product batch; these are issued per state and per harvest.
  5. Financial condition — the most recent earnings release, given ongoing restructuring activity in the U.S. MSO sector [5][6].

Profile last checked: 2025. This article is informational and not investment, legal, or medical advice.

Sources

  1. Reported Schaneman, B. (2023). Columbia Care officially changes name to Cannabist Co. MJBizDaily, September 2023.
  2. Reported Green Market Report. (2023). Columbia Care rebrands as The Cannabist Company.
  3. Government Cannabist Company Holdings Inc. — corporate filings, SEDAR+ (Canadian securities regulators).
  4. Reported Schaneman, B. (2023). Cresco Labs, Columbia Care call off $2 billion merger. MJBizDaily, July 2023.
  5. Reported MJBizDaily coverage of The Cannabist Company asset divestitures and refinancing, 2024.
  6. Reported Green Market Report — ongoing coverage of The Cannabist Company financial results.
  7. Government U.S. Drug Enforcement Administration. Drug Scheduling — Marijuana (Schedule I).

How this page was made

Generation history

May 28, 2026
Fact-check pass — raised 2 flags
May 27, 2026
Initial draft

Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.